openPR Logo
Press release

Steady Expansion Forecast for Central Fill Pharmacy Automation Market, Projected to Reach $1.1 Billion by 2029

08-05-2025 07:00 AM CET | Health & Medicine

Press release from: The Business Research Company

Central Fill Pharmacy Automation Market Size

Central Fill Pharmacy Automation Market Size

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Central Fill Pharmacy Automation Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the central fill pharmacy automation market has experienced a rapid expansion. It is projected to increase from $0.64 billion in 2024 to $0.71 billion in 2025, with a compound annual growth rate (CAGR) of 11.9%. The historical growth can be traced back to an upsurge in prescription volume, scarcity of labour, the need for precision and safety in medication, escalating healthcare expenses, and burgeoning pharmacy services.

Central Fill Pharmacy Automation Market Size Forecast: What's the Projected Valuation by 2029?
The market size of central fill pharmacy automation is projected to experience a swift expansion in the following years, reaching a value of $1.1 billion by 2029 at a compounded annual rate of growth (CAGR) of 11.5%. Several factors contribute to this growth in the expected period, including an increased demand for prescriptions, a focus on patient safety and quality, the need for regulatory compliance, and the rise of E-commerce and telepharmacy. Paramount trends for this period take into account the integration of telehealth and remote monitoring, interoperability and the exchange of health information, regulations, and assurance of quality, as well as initiatives for sustainability and ecological responsibility.

View the full report here:
https://www.thebusinessresearchcompany.com/report/central-fill-pharmacy-automation-global-market-report

What Are the Drivers Transforming the Central Fill Pharmacy Automation Market?
The escalating demand to reduce medication mistakes is predicted to fuel the expansion of the central fill pharmacy automation market. Medication blunders are avoidable incidents that can potentially lead to improper drug use or harm to the patient. These errors are on the rise due to complexities in healthcare systems, burgeoning patient loads, and the advent of new drugs. Central fill pharmacy automation simplifies the drug dispersal process, guaranteeing precise and consistent preparation of prescriptions. It curbs human mistakes and boosts efficiency in managing substantial prescription volumes. For example, as per the World Health Organization, a Swiss intergovernmental organization, in September 2022, medication mistakes amounted to $2.16 billion, or 3% of the entire national healthcare spending. About 237 million drug errors are reported annually, with around 66 million potentially clinically significant. The avoidable adverse reactions to medications reportedly cost the government an estimated $106.24 million per year. Consequently, the increasing urgency to lessen medication mishaps is propelling the central fill pharmacy automation market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15538&type=smp

What Long-Term Trends Will Define the Future of the Central Fill Pharmacy Automation Market?
Leading businesses in the central fill pharmacy automation market are prioritizing the development of cutting-edge solutions, such as cloud-based pharmacy automation, to establish a competitive presence in the market. The term cloud-based pharmacy automation denotes the application of cloud computing technology in easing and managing activities in the pharmacy sector. For example, in February 2024, Innovation Associates Inc., an American corporation known for creating high-volume pharmacy automation technology and software solutions, introduced Shared Central Fulfillment, an innovative cloud-based solution. This solution equips pharmacy fulfillment proprietors to provide centralized fulfillment services to numerous pharmacy associates from one fulfillment center. The solution is curated to result in a more adaptable work environment for pharmacy providers, thereby enhancing the role of pharmacists in healthcare. It empowers large-scale and petite pharmacy operations to leverage central fill processes, extending prescription fulfillment options to various pharmacy partners from a single hub.

Which Segments in the Central Fill Pharmacy Automation Market Offer the Most Profit Potential?
The central fill pharmacy automation market covered in this report is segmented -

1) By Product: Equipment, Software, Services
2) By Vendor: Equipment Vendor, Consulting Vendor
3) By Application: Inpatient Pharmacy, Outpatient Pharmacy, Retail Pharmacy, Other Applications

Subsegments:
1) By Equipment: Robotic Dispensing Systems, Automated Medication Storage Systems, Barcode Scanning Systems, Medication Counting Machines, Automated Labeling Systems, Packaging Systems, Other Pharmacy Automation Equipment
2) By Software: Prescription Management Software, Inventory Management Software, Workflow Management Software, Data Analytics And Reporting Software, Medication Verification Software, Integration And Interoperability Software, Cloud-Based Software Solutions
3) By Services: Installation And Configuration Services, Maintenance And Support Services, Consulting Services, Training Services, Managed Services, System Upgrades And Customization Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15538&type=smp

Which Firms Dominate the Central Fill Pharmacy Automation Market by Market Share and Revenue in 2025?
Major companies operating in the central fill pharmacy automation market are McKesson Corporation, Cencora Inc., Cardinal Health Inc., Becton inson and Company, Grifols SA, Kuka AG, J M Smith Corporation, Omnicell Inc., Swisslog Healthcare, Parata Systems LLC, ScriptPro LLC, PBA Health, Capsa Healthcare, Cornerstone Automation Systems LLC, ARxIUM Inc., Talyst LLC, Kirby Lester, Quality Manufacturing Systems Inc., R/X Automation Solutions, RxSafe LLC, Innovation Associates Inc.

Which Regions Offer the Highest Growth Potential in the Central Fill Pharmacy Automation Market?
North America was the largest region in the central fill pharmacy automation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the central fill pharmacy automation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15538

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Steady Expansion Forecast for Central Fill Pharmacy Automation Market, Projected to Reach $1.1 Billion by 2029 here

News-ID: 4132544 • Views:

More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Pharmacy

Pharmacy Automation Systems Market Analysis By Top Keyplayers - Inpatient Pharma …
The "Pharmacy Automation Systems Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Pharmacy Automation Systems Market, 2024-2031 Verified Market Research's most recent report, "Pharmacy Automation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides
Convenient and reliable online pharmacy - Onlinepills pharmacy
Onlinepills Pharmacy is a trusted and reliable online pharmaceutical company that has been serving the global community for over a decade. Onlinepills Pharmacy ensures and prioritizes customer interest with premium customer assistance and the best offers on prescription medicines. Key Benefits at Onlinepills Pharmacy: • No prescriptions are asked to order medicines. • Genuine medicines at the best price. • Medicines undergo quality checks before shipping in discreet and safe packages. • Tracking details are provided after shipping
Pharmacy Compounding For Veterinary Medicine Market Next Big Thing | Medisca, Lo …
Worldwide Pharmacy Compounding For Veterinary Medicine Market In-depth Research Report 2021, Forecast to 2026 is the latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities, and leveraging with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Worldwide Pharmacy Compounding For Veterinary Medicine Market. Some of the key players
Compounding Pharmacy Market Competitive Outlook Covering COVID-19 Impact | Lorra …
The role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs in the market. Compounded drugs are the amalgamation of two or more drug ingredients in different proportions, i.e., combining or altering the active pharmaceutical ingredients of drugs to meet the unmet medical need of an individual patient. The major driver of compounding pharmacies market is
Compounding Pharmacy Market SWOT Analysis by Key Players: Olympia Pharmacy, Wedg …
Latest Market intelligence report released by HTF MI with title "Global Compounding Pharmacy Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)" is designed covering micro level of analysis by manufacturers and key business segments. The Global Compounding Pharmacy Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is